EyePoint, Inc. (EYPT)
14.91
+0.10
(+0.68%)
USD |
NASDAQ |
Apr 17, 16:00
14.85
-0.06
(-0.40%)
After-Hours: 05:22
EyePoint SG&A Expense (Quarterly) : 11.38M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | 30.62M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| ACADIA Pharmaceuticals, Inc. | 155.62M |
| Vertex Pharmaceuticals, Inc. | 487.00M |
| Cellectar Biosciences, Inc. | 2.532M |